爱尔眼科
(300015)
| 流通市值：1011.20亿 | | | 总市值：1189.19亿 |
| 流通股本：79.31亿 | | | 总股本：93.27亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 6,026,140,250.98 | 20,982,894,148.5 | 16,301,500,342.75 | 10,545,229,547.24 |
| 营业收入 | 6,026,140,250.98 | 20,982,894,148.5 | 16,301,500,342.75 | 10,545,229,547.24 |
| 二、营业总成本 | 4,570,692,763.37 | 16,628,942,161.66 | 12,268,216,804.7 | 8,156,999,586.73 |
| 营业成本 | 3,132,566,326.27 | 10,886,548,798.66 | 7,984,744,713.2 | 5,331,661,022.88 |
| 税金及附加 | 12,070,736.76 | 66,734,642.15 | 44,118,998.03 | 27,022,910.8 |
| 销售费用 | 544,284,495.4 | 2,151,670,355.18 | 1,640,037,750.51 | 1,120,052,979.17 |
| 管理费用 | 761,077,771.03 | 2,989,059,100.52 | 2,225,346,478.18 | 1,425,762,350.84 |
| 研发费用 | 78,772,510.94 | 320,631,154.37 | 233,150,517.78 | 148,641,766.55 |
| 财务费用 | 41,920,922.97 | 214,298,110.78 | 140,818,347 | 103,858,556.49 |
| 其中:利息费用 | 69,514,250.67 | 255,561,402.92 | 184,652,799.88 | 120,387,467.06 |
| 其中:利息收入 | 20,039,529.55 | 96,046,345.49 | 76,032,588.72 | 53,985,575.03 |
| 加:公允价值变动收益 | 3,323,448.53 | 334,397,998.78 | 214,300,608.2 | 170,025,596.68 |
| 加:投资收益 | 27,992.53 | 213,220,184.07 | 148,922,310.66 | 84,800,202.12 |
| 资产处置收益 | 596,021.35 | 4,268,866.2 | 3,959,688.25 | 5,631,246.45 |
| 资产减值损失(新) | - | -187,757,063.3 | -560,450.44 | -573,862.98 |
| 信用减值损失(新) | -36,464,658.4 | -112,108,903.15 | -58,350,296.17 | -25,378,880.86 |
| 其他收益 | 12,699,468.05 | 218,944,390.36 | 102,272,589.9 | 92,541,661.23 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 1,435,629,759.67 | 4,824,917,459.8 | 4,443,827,988.45 | 2,715,275,923.15 |
| 加:营业外收入 | 1,686,462.8 | 22,024,632.78 | 9,976,995.69 | 3,946,936.94 |
| 减:营业外支出 | 33,196,201.89 | 252,659,826.68 | 105,977,189.17 | 59,757,511.74 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 1,404,120,020.58 | 4,594,282,265.9 | 4,347,827,794.97 | 2,659,465,348.35 |
| 减:所得税费用 | 237,601,059.51 | 858,152,583.94 | 679,621,278.09 | 450,761,481.29 |
| 六、净利润 | 1,166,518,961.07 | 3,736,129,681.96 | 3,668,206,516.88 | 2,208,703,867.06 |
| 持续经营净利润 | 1,166,518,961.07 | 3,736,129,681.96 | 3,668,206,516.88 | 2,208,703,867.06 |
| 归属于母公司股东的净利润 | 1,049,755,960.4 | 3,556,055,831.7 | 3,451,768,879.59 | 2,049,880,847.74 |
| 少数股东损益 | 116,763,000.67 | 180,073,850.26 | 216,437,637.29 | 158,823,019.32 |
| (一)基本每股收益 | 0.11 | 0.38 | 0.37 | 0.22 |
| (二)稀释每股收益 | 0.11 | 0.38 | 0.37 | 0.22 |
| 八、其他综合收益 | 61,714,095.38 | -91,049,313.04 | -3,449,938.8 | -54,894,343.19 |
| 归属于母公司股东的其他综合收益 | 62,591,565.22 | -74,759,095.49 | -10,855,829.74 | -54,724,918.78 |
| 九、综合收益总额 | 1,228,233,056.45 | 3,645,080,368.92 | 3,664,756,578.08 | 2,153,809,523.87 |
| 归属于母公司股东的综合收益总额 | 1,112,347,525.62 | 3,481,296,736.21 | 3,440,913,049.85 | 1,995,155,928.96 |
| 归属于少数股东的综合收益总额 | 115,885,530.83 | 163,783,632.71 | 223,843,528.23 | 158,653,594.91 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-31 | 2024-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |